Page title
Section title
DNA Income Statement Key Metrics
- Revenue(TTM)184.34 M
- Gross Profit(TTM)108.34 M
- EBITDA(TTM)-459.73 M
- Net Income(TTM)-897.68 M
- EPS Diluted(TTM)-13.75
Decode DNA's Latest Earnings Call with Ease
Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!
DNA earnings and revenue history
DNA Return on Equity
See how efficiently DNA generates profit for it's shareholders.
0%
Poor
Average
Strong
Return on Equity Growth
DNA's Return on Equity has shown poor growth over the past 10 years, increasing by only 0%.
DNA Revenue Growth
See how DNA has grown it's revenue over the past 10 years.
Revenue Growth
DNA's revenue has grown significantly over the past 10 years, increasing by over 16.95%.
DNA FY, 2023 Revenue Breakdown
See how DNA converts it's revenue into profit.
DNA Balance Sheet Health
DNA Balance Sheet Breakdown 2023
Assets
Long Term Assets
Cash & Equivalents
Inventory
Receivables
Property Plant Equipments
Others
Liabilities
Short Term Debt
Long Term Debt
Account Payables
Others
DNA financial position analysis
Short Term Liabilities
DNA's short term assets($1B) can safely cover it's short term liabilities($164M).
Long Term Liabilities
DNA's short term assets($1B) can safely cover it's long term liabilities($404M).